Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1990 Nov;81(11):1155–1161. doi: 10.1111/j.1349-7006.1990.tb02528.x

Monoclonal Anti‐P‐glycoprotein Antibody‐dependent Killing of Multidrug‐resistant Tumor Cells by Human Mononuclear Cells

Yuji Heike 1, Hirofumi Hamada 1, Noriaki Inamura 2, Saburo Sone 2, Takeshi Ogura 2, Takashi Tsuruo 1,3,✉
PMCID: PMC5917982  PMID: 1979977

Abstract

Mouse monoclonal antibodies (MRK16 and MRK17) against human multidrug‐resistant cancer cell lines were tested for antibody‐dependent cytotoxicity mediated by human blood mononuclear cells, using a 4‐h 51Cr release assay. MRK16 (IgG28 isotype) was shown to be more effective than MRK17 (IgG1 isotype). Moreover, when four pairs of drug‐resistant and their parent sensitive human cancer cells were tested for antibody‐dependent cell‐mediated cytolysis (ADCC) using MRK16, only the drug‐resistant cell lines were susceptible to ADCC reaction. When highly purified lymphocytes (>99%) and monocytes (>97%) were isolated from blood mononuclear cells by centrifugal elutriation and adherence, MRK16 promoted both lymphocyte‐ and monocyte‐mediated tumor cell killing, whereas MRK17 induced only a lymphocyte‐mediated ADCC reaction. These results suggest that MRK16 of IgG28 subtype may be a useful therapeutic agent in eradication of drug‐resistant cancer cells expressing P‐glycoprotein through ADCC reaction.

Keywords: Multidrug resistance, P‐glycoprotein, Monoclonal antibody, Human mononuclear cells

Full Text

The Full Text of this article is available as a PDF (410.8 KB).

REFERENCES

  • 1. ) Riordan , J. R. and Ling , V.Genetic and biochemical characterization of multidrug resistance . Pharmacol. Ther. , 28 , 51 – 75 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Hamada , H. and Tsuruo , T.Monoclonal antibodies against multidrug resistant cell lines . Proc. Am. Assoc. Cancer Res. , 27 , 390 ( 1986. ). [Google Scholar]
  • 3. ) Safa , A. R. , Glover , C. J. , Meyers , M. B. , Biedler , J. L. and Felsted , R. L.Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug‐resistant cells . J. Biol. Chem. , 261 , 6137 – 6140 ( 1986. ). [PubMed] [Google Scholar]
  • 4. ) Cornwell , M. M. , Safa , A. R. , Felsted , R. L. , Gottesman , M. M. and Pastan , T.Membrane vesicles from multidrug resistant human cancer cells contain a specific 150‐ to 170‐kDa protein detected by photoaffinity labeling . Proc. Natl. Acad. Sci. USA , 83 , 3847 – 3850 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Hamada , H. and Tsuruo , T.Purification of the 170‐ to 180‐kilodalton membrane glycoprotein associated with multidrug resistance: the 170‐ to 180‐kilodalton membrane glycoprotein is an ATPase . J. Biol. Chem. , 263 , 1454 – 1458 ( 1988. ). [PubMed] [Google Scholar]
  • 6. ) Hamada , H. and Tsuruo , T.Characterization of the ATPase activity of the 170‐ to 180‐kilodalton membrane glycoprotein (P‐glycoprotein) associated with multidrug resistance . Cancer Res. , 48 , 4926 – 4932 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Willingham , M. C. , Richert , N. D. , Cornwell , M. M. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. and Pastan , I. H.Immunocytochemical localization of P170 at the plasma membrane of multidrug‐resistant human cells . J. Histochem. Cytochem. , 35 , 1451 – 1456 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Sugawara , I. , Kataoka , I. , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multidrug‐resistant gene as revealed by a monoclonal antibody, MRK16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). [PubMed] [Google Scholar]
  • 9. ) Shen , D‐W. , Fojo , A. , Roninson , I. B. , Chin , J. E. , Soffir , R. , Pastan , I. and Gottesman , M. M.Multidrug resistance in DNA mediated transformants is linked to tranfer of the human mdr 1 gene . Mol Cell Biol. , 6 , 4039 – 4045 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Gros , P. , Neriah , U. B. , Croop , J. M. and Housman , D. E.Isolation and expression of a complementary DNA (mdr) that confers multidrug resistance . Nature , 323 , 728 – 731 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Ueda , K. , Cardarelli , C. , Gottesman , M. M. and Pastan , I.Expression of a full‐length cDNA for the human mdr1 (P‐glycoprotin) gene confers multidrug‐resistance . Proc. Natl. Acad. Sci. USA , 84 , 3004 – 3008 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Tsuruo , T. , Iida‐Saito , H. , Kawabata , H. , Oh‐hara , T. , Hamada , M. and Utakoji , T.Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones . Jpn. J. Cancer Res. , 11 , 682 – 692 ( 1986. ). [PubMed] [Google Scholar]
  • 13. ) Akiyama , S. , Fojo , A. , Hanover , J. and Pastan , I.Isolation and genetic characterization of human KB cell lines resistant to multiple drugs . Somatic Cell Mol. Genet. , 11 , 117 – 126 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Beck , W. T. , Mueller , T. J. and Tanzer , L. R.Altered surface membrane glycoproteins in vinca alkaloid‐resistant human leukemic lymphoblasts . Cancer Res. , 39 , 2070 – 2076 ( 1979. ). [PubMed] [Google Scholar]
  • 15. ) Herlyn , D. and Koprowski , H.IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells . Proc. Natl. Acad. Sci. USA , 79 , 4761 – 4765 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Larson , L. N. , Johansson , C. , Lindholm , L. and Holmgren , J.Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells . Int. J. Cancer , 42 , 877 – 882 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Eisenthal , A. , Lafreniere , R. , Lefor , A. L. and Rosenberg , S. A.Effect of anti‐B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases . Cancer Res. , 47 , 2771 – 2776 ( 1987. ). [PubMed] [Google Scholar]
  • 18. ) Matthews , T. J. , Weinhold , K. J. , Langlois , A. J. and Bolognese , D. P.Immunologic control of a retrovirus‐associated murine adenocarcinoma. VI. Augmentation of antibody dependent killing following quantitative and qualitative changes in host peritoneal cells . J. Natl. Cancer Inst. , 75 , 703 – 708 ( 1985. ). [PubMed] [Google Scholar]
  • 19. ) Weinhold , K. J. , Bolognesi , D. P. and Matthews , T. J.Immunological control of a retrovirus associated murine adenocarcinoma. VIII. Corynebacterium parvum activated natural killer cells as a potent antibody dependent cell mediated cytotoxicity effector . J. Natl. Cancer Inst. , 75 , 717 – 724 ( 1985. ). [PubMed] [Google Scholar]
  • 20. ) Santoni , A. , Herberman , R. B. and Holden , H. T.Correlation between natural and antibody dependent cell mediated cytotoxicity against tumor targets in the mouse. II. Characterization of effector cells . J. Natl. Cancer Inst. , 63 , 995 – 1003 ( 1979. ). [PubMed] [Google Scholar]
  • 21. ) Brunda , M. J. , Herberman , R. B. and Holden , H. T.Antibody induced augmentation of murine natural killer cell activity . Int. J. Cancer , 27 , 205 – 211 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Schulz , G. , Staffileno , L. K. , Reisfeld , R. A. and Denner , G.Eradication of established human melanoma tumors in nude mice by antibody directed effector cells . J. Exp. Med. , 161 , 1315 – 1325 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Tsuruo , T. , Hamada , H. , Sato , S. and Heike , Y.Inhibition of multidrug‐resistant human tumor growth in athymic mice by anti‐P‐glycoprotein monoclonal antibodies . Jpn. J. Cancer Res. , 80 , 627 – 631 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Hamada , H. and Tsuruo , T.Growth inhibition of multi‐drug‐resistant cells by monoclonal antibodies against P‐glycoprotein . In “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells ,” ed. Roninson I. B. , In press ( 1989. ). Plenum Publishing Corp. , New York . [Google Scholar]
  • 25. ) Sugimoto , Y. , Roninson , I. B. and Tsuruo , T.Decreased expression of the amplified mdrl gene in revertants of multidrug‐resistant human myelogenous leukemia K562 occurs without a loss of the amplified DNA . Mol. Cell Biol. , 7 , 4549 – 4552 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Utsugi , T. and Sone , S.Comparative analysis of the priming effect of human interferon‐γ, α and β on synergism with muramyl dipeptide analog for antitumor expression of human blood monocytes . J. Immunol. , 136 , 1117 – 1122 ( 1986. ). [PubMed] [Google Scholar]
  • 27. ) Sone , S. , Tandon , P. , Utsugi , T. , Ogawa , M. , Shimizu , E. , Nii , A. and Ogura , T.Synergism of recombinant human interferon gamma with liposome‐encapsulated muramyl tripeptide in activation of the tumoricidal properties of human monocytes . Int. J. Cancer , 38 , 495 – 500 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Sone , S. , Utsuge , T. , Shirahama , T. , Ishii , K. , Mutsuura , S. and Ogawara , M.Induction by interferon‐α of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells . J. Biol. Response Modif. , 4 , 134 – 140 ( 1985. ). [PubMed] [Google Scholar]
  • 29. ) Hamada , H. and Tsuruo , T.Functional role for the 170‐to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. ) Goding , J. W. “ Monoclonal Antibodies; Principles and Practice ,” p. 18 ( 1983. ). Academic Press; , London . [Google Scholar]
  • 31. ) Smith , P. K. , Krohn , R. I. , Hermanson , G. T. , Mallia , A. K. , Gartner , F. H. , Provenzano , M. D. , Fujimoto , E. K. , Goeke , N. M. , Olson , B. J. and Klenk , D. C.Measurement of protein using bicinchoninic acid . Anal. Biochem. , 150 , 76 – 85 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Shiiloni , E. , Eisenthal , A. , Sachs , D. and Rosenberg , S. A.Antibody dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin‐2 . J. Immunol. , 138 , 1992 – 1998 ( 1987. ). [PubMed] [Google Scholar]
  • 33. ) Giorgio , T. and Bice , P.Immune interferon: a pleiotropic lymphokine with multiple effects . Immunol. Today , 6 , No. 4 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Munn , D. H. and Cheung , N‐K. V.Interleukin‐2 enhancement of monoclonal antibody‐mediated cellular cytotoxicity against human melanoma . Cancer Res. , 47 , 6600 – 6605 ( 1987. ). [PubMed] [Google Scholar]
  • 35. ) Eisenthal , A. , Cameron , R. B. , Uppenkamp , I. and Rosenberg , S. A.Effect of combined therapy with lymphokine‐activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases . Cancer Res. , 48 , 7140 – 7145 ( 1988. ). [PubMed] [Google Scholar]
  • 36. ) Steplewski , Z. , Lebeck , M. D. and Koprowski , H.Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells . Science , 221 , 865 – 867 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Sears , H. F. , Atkinson , B. , Mattis , J. , Ernst , C. , Herlyn , D. , Steplewski , Z. , Hoyry , P. and Koprowski , H.Phase‐1 clinical trial of monoclonal antibody in treatment of gastrointestinal tumors . Lancet , i , 762 – 765 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Sears , H. F. , Herlyn , D. , Sreplewski , Z. and Koprowki , H.Phase 2 clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma . Cancer Res. , 45 , 5910 – 5913 ( 1985. ). [PubMed] [Google Scholar]
  • 39. ) Fojo , A. T. , Ueda , K. , Slamon , D. J. , Poplack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multi‐drug‐resistance gene in human tumors and tissues . Proc. Natl. Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. ) Thiebaut , F. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. , Pastan , I. and Willingham , M. C.Cellular localization of the multidrug‐resistance gene product P‐glycoprotein in normal human tissues . Proc. Natl. Acad. Sci. USA , 84 , 7735 – 7738 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. ) Sugawara , I. , Nakahama , M. , Hamada , H. , Tsuruo , T. and Mori , S.Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000–180,000 P‐glycoprotein . Cancer Res. , 48 , 4611 – 4614 ( 1988. ). [PubMed] [Google Scholar]
  • 42. ) Cordon‐Cardo , C. , 'Brien , J. P. , Casals , D. , Rittman‐Grauer , L. , Biedler , J. L. , Melamed , M. R. and Bertino , J. R.Multidrug‐resistant gene (P‐glycoprotein) is expressed by endothelial cells at blood‐brain barrier sites . Proc. Natl. Acad. Sci. USA , 86 , 695 – 698 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES